Articles about Cancer – Page 2 of 4

Microsoft joins with Pacific NW medical research institutions on data discovery platform

Microsoft is teaming up with leading medical research organizations to create a shared network of research data in the Pacific… Read More

Podcast

Why this cancer researcher (and survivor) is climbing Kilimanjaro to raise money to study cancer

Kristin Anderson has already fought cancer in more ways than one. She’s a cancer survivor whose battle with breast cancer… Read More

Amgen and University of Washington’s Institute for Protein Design team up to build better cancer drugs

Biotech giant Amgen is putting up the money to fund three research projects in partnership with the University of Washington’s… Read More

This giant, inflatable colon needs a name: Fred Hutch offering $50 to winning entry in contest

The Fred Hutchinson Cancer Research Center in Seattle wants to raise awareness about colorectal health in underserved communities across Washington… Read More

Historic steam plant in Seattle gets a fresh new look courtesy of Fred Hutch

The Fred Hutchinson Cancer Research Center has a historic new signpost on Seattle’s Lake Union. The institution has started adding… Read More

Seattle startup Blaze Bioscience makes brain tumors ‘light up like a Christmas tree’ in first trial

Blaze Bioscience, a Seattle-based biotech company that’s using a protein borrowed from scorpion venom to make cancerous tumors glow, has… Read More

Algorithms help spot cancer ‘lottery winners’ in new Fred Hutch study

For most patients, a diagnosis of stage 4 non-small cell lung cancer comes with a dire prognosis. But for patients… Read More

Merck research chief Roger Perlmutter touts Seattle biotech strength after $300M Immune Design deal

Two months after Merck acquired Seattle-based biotech Immune Design for $300 million, the president of Merck Research Laboratories, Roger Perlmutter,… Read More

Navigating Cancer lands $12M, inks McKesson partnership to help doctors engage with patients

Seattle-based startup Navigating Cancer has raised $12 million for its digital platform that lets cancer doctors interact with their patients.… Read More

3 leadership lessons from Adaptive Biotechnologies CEO Chad Robins

As the CEO of Adaptive Biotechnologies, Chad Robins has shown a knack for turning really good ideas into a viable… Read More

Seattle biotech startup Good Therapeutics raises $11M to make smart cancer therapies

Good Therapeutics, a new Seattle biotech startup that aims to develop protein drugs that act only when needed, raised $11… Read More

Seattle Genetics shares slump after losses grow

Seattle Genetics on Thursday reported higher-than-expected losses for the fourth quarter, sending shares down 8 percent in after-hours trading. Quarterly… Read More

Fred Hutch researchers root out sleeping breast cancer cells to stop metastasis

Researchers at the Fred Hutchinson Cancer Research Center led by Dr. Cyrus Ghajar recently uncovered promising new science in the… Read More

Geek of the Week: Fred Hutch’s Steve Pergam caught a ‘bug’ for infectious diseases and research

Although Steve Pergam grew up with parents who were both physicians, he was never pushed to be a doctor as… Read More

Bristol-Myers Squibb’s $74B acquisition of Juno parent Celgene puts Seattle biotech world on alert

Things are a little on edge in Seattle’s biotech scene after the Jan. 3 announcement that pharmaceutical giant Bristol-Myers Squibb… Read More

New Seattle startup emerges from UW to develop cancer-fighting protein three decades in the making

For 30 years, scientists have been trying to unleash the promise of Interleukin-2 (IL-2), a powerful protein that fights cancer… Read More

Adaptive Biotechnologies signs blockbuster deal with Genentech for personalized cancer treatments worth up to $2 billion

Adaptive Biotechnologies has signed a $300 million collaborative licensing agreement with Genentech to develop highly personalized cancer therapies. In addition… Read More

Biotech startup Kineta inks cancer deal with Pfizer worth up to $505M

Seattle-based biotech startup Kineta today received a leg-up in its efforts to kill cancerous tumors using the immune system. Kineta announced an… Read More

Cancer drug maker CTI BioPharma lays off 50% of workforce

CTI BioPharma announced Thursday that it will let go of half its employees in order to create more runway to… Read More

Allen Institute launches new immunology division with $125M from its late founder

Billionaire philanthropist Paul Allen died two months ago, but before he passed away, he passed along a $125 million commitment… Read More

Biotech journalist Luke Timmerman sets his sights on Mount Kilimanjaro and $1M for cancer research

As a journalist, Luke Timmerman has covered biotech for more than 17 years. Now, the Timmerman Report founder is making… Read More

Allen Frontiers Group awards $13.5M for research on cancer, cells, aging and brains

It’s notable that the newest class of Allen Distinguished Investigators, announced today by the Paul G. Allen Frontiers Group, includes… Read More

Boeing and ISS National Lab award $500,000 to boost cancer research in orbit

For the fifth year in a row, Boeing and the International Space Station’s U.S. national laboratory are partnering to pay… Read More

The cancer that changed the course of Paul Allen’s life, and shaped his legacy

“I felt as bulletproof as most people under thirty. I took my health for granted.” That’s how Paul Allen, the… Read More

Paul Allen says non-Hodgkin’s lymphoma has returned but voices optimism about fighting it

Nine years after he underwent treatment for non-Hodgkin’s lymphoma, a potentially fatal but treatable form of cancer, Microsoft co-founder Paul… Read More

Researchers use tiny tricks to pull out precious protein data from a single cell

Scientists have developed a technique that can analyze fluid from a single human cell to identify its proteins — which could… Read More

Grail raises $300M for cancer detection tools, boosting total investment to $1.5B

News Brief: Grail, a biotech company with early backing from Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos, says… Read More

Seattle biotech journalist reaches summit of Mount Everest in bid to raise money for cancer research

Seattle biotech journalist Luke Timmerman reached new heights Tuesday in his efforts to raise awareness for cancer research by successfully… Read More

Podcast

Health Tech Podcast: Using precision medicine to kill cancer — with artificial intelligence

In December of 2012, Su-In Lee was working at the University of Washington in Seattle. One day, she got the… Read More

Cancer researchers report positive results for larotrectinib, a ‘tumor-agnostic’ drug

Two clinical studies have provided evidence suggesting that an experimental precision-medicine drug called larotrectinib can fight soft-tissue tumors regardless of… Read More